Literature DB >> 15466175

Monoallelic methylation of the APC promoter is altered in normal gastric mucosa associated with neoplastic lesions.

Geneviève Clément1, Fred T Bosman, Charlotte Fontolliet, Jean Benhattar.   

Abstract

Adenomatous polyposis coli (APC) promoter hypermethylation has been reported frequently in normal gastric mucosa, but it remained to be clarified whether this occurs in every individual. In this study, methylation of the APC promoter was analyzed in histologically normal-appearing gastric mucosa samples by methylation-sensitive single-strand conformation analysis and by a methylation-sensitive dot blot assay. Epithelial cell samples were collected by microdissection from tissue sections. Equal amounts of methylated and unmethylated APC alleles were found in all gastric mucosa samples from patients without any gastric lesions (20 samples). Allele-specific methylation analysis showed that the methylation of the APC promoter was monoallelic; however, which allele was methylated depended on the cell type. Increased or decreased methylation was found in 10 of 36 (28%) normal gastric mucosa samples adjacent to a gastric or esophageal adenocarcinoma. No allelic loss was found at the APC locus. Modification of the methylation status was also found in 3 of 21 (14%) normal-appearing gastric mucosa samples adjacent to intestinal metaplasia. In contrast, all normal mucosa samples in cases with chronic gastritis but without metaplasia or dysplasia showed a monoallelic methylation pattern. Our results indicate the following: (a) In normal gastric mucosa, the APC promoter shows monoallelic methylation, which is not due to imprinting but most likely due to allelic exclusion; (b) the excluded allele differs between foveolar and glandular epithelial cells; (c) the APC methylation pattern is frequently altered in normal-appearing gastric mucosa of gastric or esophageal adenocarcinoma patients; and (d) such alterations also occur in normal gastric mucosa adjacent to intestinal metaplasia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466175     DOI: 10.1158/0008-5472.CAN-03-2503

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Techniques used in studies of epigenome dysregulation due to aberrant DNA methylation: an emphasis on fetal-based adult diseases.

Authors:  Shuk-mei Ho; Wan-yee Tang
Journal:  Reprod Toxicol       Date:  2007-01-19       Impact factor: 3.143

2.  Methylation of the Tumor Suppressor Gene RUNX3 in Human Gastric Carcinoma.

Authors:  Hyun Joo Song; Ki-Nam Shim; Yang-Hee Joo; Seong-Eun Kim; Sung-Ae Jung; Kwon Yoo
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

3.  Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.

Authors:  Timothy M Barrow; Hagen Klett; Reka Toth; Jürgen Böhm; Biljana Gigic; Nina Habermann; Dominique Scherer; Petra Schrotz-King; Stephanie Skender; Clare Abbenhardt-Martin; Lin Zielske; Martin Schneider; Alexis Ulrich; Peter Schirmacher; Esther Herpel; Hermann Brenner; Hauke Busch; Melanie Boerries; Cornelia M Ulrich; Karin B Michels
Journal:  J Pathol       Date:  2017-09-29       Impact factor: 7.996

4.  Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients.

Authors:  Jan Dimberg; Thai Trinh Hong; Marita Skarstedt; Sture Löfgren; Niklas Zar; Andreas Matussek
Journal:  Oncol Lett       Date:  2012-10-12       Impact factor: 2.967

5.  The aberrant asynchronous replication - characterizing lymphocytes of cancer patients - is erased following stem cell transplantation.

Authors:  Arnon Nagler; Samuel Cytron; Maya Mashevich; Avital Korenstein-Ilan; Lydia Avivi
Journal:  BMC Cancer       Date:  2010-05-24       Impact factor: 4.430

6.  Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.

Authors:  Dimitrios Matthaios; Ioanna Balgkouranidou; Anastasios Karayiannakis; Helen Bolanaki; Nikolaos Xenidis; Kyriakos Amarantidis; Leonidas Chelis; Konstantinos Romanidis; Aikaterini Chatzaki; Evi Lianidou; Grigorios Trypsianis; Stylianos Kakolyris
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

Review 7.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

8.  Analysis of the methylation patterns of the p16 INK4A, p15 INK4B, and APC genes in gastric adenocarcinoma patients from a Brazilian population.

Authors:  Bárbara do Nascimento Borges; Rommel Mario Rodriguez Burbano; Maria Lúcia Harada
Journal:  Tumour Biol       Date:  2013-03-17

9.  APC promoter 1B deletion in seven American families with familial adenomatous polyposis.

Authors:  A K Snow; T M F Tuohy; N R Sargent; L J Smith; R W Burt; D W Neklason
Journal:  Clin Genet       Date:  2014-10-14       Impact factor: 4.438

10.  Progressive silencing of p14ARF in oesophageal adenocarcinoma.

Authors:  Yinghui Huang; Christopher J Peters; Rebecca C Fitzgerald; Ruth A Gjerset
Journal:  J Cell Mol Med       Date:  2008-04-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.